top of page
Speakers
*More speakers to be announced shortly
Patrik Andersson, Ph.D.
AstraZeneca
Aravind Asokan, Ph.D.
Duke Department of Surgery
Peter Beal, Ph.D.
UC Davis Chemistry
Alan Brown, MD
Advocate Aurora Health
Olga Anczukow Camarda, Ph.D.
The Jackson Laboratory for Genomic Medicine
Thomas Carell Ph.D.
Ludwig-Maximilians-Universität (LMU) München
Don Cleveland, Ph.D.
UC San Diego
Rob Collin, Ph.D.
Radboud University Medical Center
Steven Ferguson, Ph.D.
University College Dublin
Camilla Foged
University of Copenhagen
Andy Geall, Ph.D.
Replicate Bioscience, Inc.
Aurélie Goyenvalle, Ph.D.
Laboratoire Biothérapies des Maladies Neuromusculaires
Michelle Hastings, Ph.D.
University of Michigan Medical School
Maja Janas, Ph.D., DABT
Alnylam Pharmaceuticals
Aimee Jackson, Ph.D.
Atalanta Therapeutics
Steven Jones, Ph.D.
SMA Patient Advocate
Adrian R. Krainer, Ph.D.
St. Giles Foundation Professor, Cold Spring Harbor Laboratory, CSHL Cancer Center
Arthur Krieg, MD
Zola Therapeutics
Chris Li, Ph.D.
Hongene Biotech
Stefan Lutz, Ph.D.
Codexis
Ian MacRae, Ph.D.
TSRI
Brett P. Monia, Ph.D.
Ionis Pharmaceuticals, Inc.
Adam Mullick, Ph.D.
Ionis Pharmaceuticals, Inc.
Lubomir Nechev, Ph.D.
Alnylam Pharmaceuticals
Kasper Roet, Ph.D.
Founder & CEO of QurAlis
bottom of page